Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Limal

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Medicine|January 16, 2010
Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African, and black patientsLaurent Arnaud, Julien Haroche, Nicolas Limal, et al.
Annals of Hematology|August 25, 2019
Iron deficiency, an unusual cause of thrombocytopenia: results from a multicenter retrospective case-controlled studyTessa Huscenot, Luc Darnige, Orianne Wagner-Ballon, et al.
Rheumatology (Oxford, England)|October 26, 2021
Rituximab plus methotrexate combination as a salvage therapy in persistently active granulomatosis with polyangiitisBoris Sorin, Maxime Samson, Cécile-Audrey Durel, et al.
British Journal of Haematology|May 11, 2022
Characteristics, management and outcome of acquired amegakaryocytic thrombocytopeniaAnais Roeser, Guillaume Moulis, Mikael Ebbo, et al.
American Journal of Hematology|April 6, 2022
Blood exchange transfusion with dexamethasone and Tocilizumab for management of hospitalized patients with sickle cell disease and severe COVID-19: Preliminary evaluation of a novel algorithmGonzalo De Luna, Anoosha Habibi, Marie-Hélène Odièvre, et al.
Haematologica|August 21, 2020
Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase 2b trialMatthieu Mahévas, Imane Azzaoui, Etienne Crickx, et al.
The American Journal of Pathology|January 26, 2016
Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 ExpressionYves Allenbach, Gaëlle Leroux, Xavier Suárez-Calvet, et al.
Rheumatology (Oxford, England)|May 7, 2019
Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trialXavier Puéchal, Christian Pagnoux, Gabriel Baron, et al.
Journal of the American Academy of Dermatology|December 10, 2025
Tocilizumab for refractory and/or relapsing polyarteritis nodosaAdrien Cottu, Chloé Grolleau, Camille Gandon, et al.
Arthritis Research & Therapy|September 18, 2020
Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trialArsene Mekinian, David Saadoun, Eric Vicaut, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Medicine|January 16, 2010
Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African, and black patientsLaurent Arnaud, Julien Haroche, Nicolas Limal, et al.
Annals of Hematology|August 25, 2019
Iron deficiency, an unusual cause of thrombocytopenia: results from a multicenter retrospective case-controlled studyTessa Huscenot, Luc Darnige, Orianne Wagner-Ballon, et al.
Rheumatology (Oxford, England)|October 26, 2021
Rituximab plus methotrexate combination as a salvage therapy in persistently active granulomatosis with polyangiitisBoris Sorin, Maxime Samson, Cécile-Audrey Durel, et al.
British Journal of Haematology|May 11, 2022
Characteristics, management and outcome of acquired amegakaryocytic thrombocytopeniaAnais Roeser, Guillaume Moulis, Mikael Ebbo, et al.
American Journal of Hematology|April 6, 2022
Blood exchange transfusion with dexamethasone and Tocilizumab for management of hospitalized patients with sickle cell disease and severe COVID-19: Preliminary evaluation of a novel algorithmGonzalo De Luna, Anoosha Habibi, Marie-Hélène Odièvre, et al.
Haematologica|August 21, 2020
Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase 2b trialMatthieu Mahévas, Imane Azzaoui, Etienne Crickx, et al.
The American Journal of Pathology|January 26, 2016
Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 ExpressionYves Allenbach, Gaëlle Leroux, Xavier Suárez-Calvet, et al.
Rheumatology (Oxford, England)|May 7, 2019
Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trialXavier Puéchal, Christian Pagnoux, Gabriel Baron, et al.
Journal of the American Academy of Dermatology|December 10, 2025
Tocilizumab for refractory and/or relapsing polyarteritis nodosaAdrien Cottu, Chloé Grolleau, Camille Gandon, et al.
Arthritis Research & Therapy|September 18, 2020
Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trialArsene Mekinian, David Saadoun, Eric Vicaut, et al.
Pageof 8